Microvascular ischemia in the brain manifests as formation of white matter lesions (WMLs) and lacunae that ultimately result in gait disturbance, cognitive impairment, and dementia. 1,2 Most of the changes are caused by cerebral small vessel disease (SVD), but the pathogenesis of cerebral SVD is incompletely understood. 3 There is extensive literature describing the relationships between SVD and cerebrovascular risk factors such as hypertension, diabetes, and chronic kidney disease. 4, 5 Hypertension is known to be a major risk factor that contributes to the acceleration of brain damage.
Microvascular ischemia in the brain manifests as formation of white matter lesions (WMLs) and lacunae that ultimately result in gait disturbance, cognitive impairment, and dementia. 1, 2 Most of the changes are caused by cerebral small vessel disease (SVD), but the pathogenesis of cerebral SVD is incompletely understood. 3 There is extensive literature describing the relationships between SVD and cerebrovascular risk factors such as hypertension, diabetes, and chronic kidney disease. 4, 5 Hypertension is known to be a major risk factor that contributes to the acceleration of brain damage.
Recent evidence indicates that 24-hour ambulatory blood pressure monitoring (ABPM) is more useful for evaluating cardiovascular risk than casual blood pressure (BP) measurement. [6] [7] [8] [9] BP variability (BPV) over the course of many hours has been well documented by 24-hour ABPM, and previous studies reported that ambulatory blood pressure (ABP) variability predicted cardiovascular risk in hypertensive patients. [6] [7] [8] [9] However, the impact of ABP variability on SVD progression 10 and cognitive decline in elderly individuals has not been well investigated in community-based studies.
Because cognitive function and cerebral SVD are associated with age, 2 this study focused on evaluation of subjects aged 70-72 years to minimize the impact of age on the parameters studied. This longitudinal study examined the relationships between BPV evaluated by 24-hour ABPM and cerebral SVD and global cognitive function in community-dwelling elderly Japanese individuals. Brain magnetic resonance imaging (MRI) and cognitive function testing were performed at baseline and repeated 4 years later to determine whether SVD progression and cognitive decline were related to ABP variability. We also investigated whether these relationships were independent of conventional risk factors and carotid artery atherosclerosis.
METHODS

Study population
All samples and data used for this study were obtained from elderly persons living in Sagae City of Yamagata Prefecture, Japan. Sagae City has 4 areas, and all elderly persons of a specific age in each area were invited to participate in this study ( Figure 1 ). Of 490 residents (227 men and 263 women), those with contra-indications to MRI or who refused testing were excluded. The remaining 292 (59.6%) elderly persons were included in this study. Each subject underwent evaluation of their medical history using a questionnaire and blood and urine sampling, ABPM, brain MRI, cognitive testing, and ultrasonographic evaluation of the carotid arteries at baseline and repeat brain MRI and cognitive testing 4 years later. Clinical decisions regarding drug therapy were made by each subject's primary care physician. Eightytwo subjects with missing data were excluded (Figure 1) , and the data from the remaining 210 subjects (94 men and 116 women) were included in the analyses. Details of the study design were reported in our previous cross-sectional studies. 5, 11 Written informed consent was obtained from all subjects, and the study was approved by the Medical Ethics Committee of Yamagata University School of Medicine.
Evaluation of cardiovascular risk factors
As previously reported, 5, 11 hypertension was defined as a casual BP of ≥140/90 mm Hg or current use of antihypertensive agents. Serum total cholesterol, high-density lipoprotein cholesterol, triglyceride, fasting plasma glucose, and hemoglobin A1c levels were measured after an overnight fast. Subjects were defined as having hyperlipidemia if they had a total cholesterol level of ≥220 mg/dl, triglyceride level of ≥150 mg/dl, or were taking medication for hyperlipidemia. Diabetes mellitus was diagnosed according to the World Health Organization criteria. 12 Subjects with no known history of diabetes underwent a 75-g oral glucose tolerance test.
Assessment of brain MRI and definition of cerebral SVD
Brain MRI was performed using a 0.5-T scanner (Flex Art; Toshiba, Tokyo, Japan). Axial T1-weighted, T2-weighted, and fluid-attenuated inversion recovery images with 6-mm slices were examined for each subject. Subjects were defined as having cerebral SVD if the MRI showed (i) WML, defined as at least 1 focal lesion in the cerebral white matter with corresponding high-signal intensity on fluid-attenuated inversion recovery images; or (ii) lacunar infarct, defined as a 3-to 15-mm diameter area of high signal intensity on T2-weighted images with corresponding low-signal intensity on T1-weighted images. Because WMLs often coexist with lacunae and both can influence cognitive decline in the elderly, 1-3 both lesion types were considered to reflect cerebral SVD load. We compared the findings of the first and second MRI examinations to evaluate changes in cerebral SVD. If any WMLs or lacunae were found on the second MRI that were not visible on the first MRI, the subject was considered to have progression of cerebral SVD (Figure 2 ). A single trained physician who was blinded to the clinical details evaluated the existence and severity of SVD on all of the MRI examinations. In addition, the Fazekas grade was determined for the WMLs because this grade has been shown to reflect the pathological severity of cerebral SVD in postmortem examinations. 13 Because we thereafter re-evaluated the MRI again (n = 100), the repeatability (weighted kappa) of the MRI findings was good for WML grade (k = 0.86) and moderate for lacunae (k = 0.68).
ABPM and definitions of BPV
ABPM was performed on a weekday using an automated system (FB-250; Fukuda Denshi, Tokyo, Japan) that records BP using the oscillometric method. ABPM was measured every 30 minutes during the day and every 60 minutes at night, as previously described. 14 Subjects continued their normal daily activities during the ABP measurements. Based on a previous study, daytime and nighttime episodes were defined as those occurring from 8:00 am to 10:00 pm and from 12:00 am to 6:00 am, respectively. 15 The SD, weighted SD, and coefficient of variation (CV) of ABP variability were calculated. We also calculated the average real variability (ARV), which has been proposed as a reliable index inspired by the total variability concept of real analysis in mathematics. 16, 17 We calculated the weighted SD, CV, and ARV according to the following formulas: In these formulas, 14 and 6 are the numbers of hours included in the daytime and nighttime periods, respectively. N is the number of valid BP measurements, and K is the order of measurements from the ABPM data corresponding to each subject.
Assessment of carotid atherosclerosis
Carotid artery ultrasound examination was performed to obtain the plaque score, using previously reported methods. 18 
Cognitive function testing
Cognitive function was assessed using the Mini-Mental State Examination (MMSE) at baseline and 4 years later. The first and second MMSE scores were compared for each subject, and a cognitive decline was defined as a decrease of at least 1 point in the second score, as previously described. 19 
Statistical analysis
Standard descriptive statistical analyses were performed. The χ 2 test was used to compare proportions, and the unpaired t test was used to compare normally distributed data between 2 groups. Analysis of variance was used to analyze the differences between the mean values of multiple groups. The Cochran-Armitage test was used to compare the incidence of SVD progression by quartiles of indices of ABP variability (SD, weighted SD, CV, and ARV) and the incidence of cognitive decline by tertiles of indices of ABP variability. Logistic regression analysis was used to determine whether indices of ABP variability were independently associated with SVD progression or cognitive decline. ABP variability indices were divided into 2 groups by median values, and odds ratios (ORs) for the likelihood of SVD progression and cognitive decline were calculated by univariable analyses. Multiple regression analysis with inclusion of confounding factors was performed to determine whether ABP variability was independently associated with SVD progression or cognitive decline. Because we expected that the impact of ABP variability might differ according to the presence or absence of SVD at baseline, reflecting hypertensive brain damage, we calculated the ORs for SVD progression separately in the whole group and in subjects with and without SVD on the first MRI. Probability values were 2-tailed, and values of P < 0.05 were considered statistically significant. All analyses were performed with R version 3.0.1 for Windows (www.r-project.org).
RESULTS
The baseline characteristics of the subjects are shown in Table 1 . No significant differences in baseline characteristics were detected between the subjects included in the analyses and those who were excluded (Supplementary Table S1 ).
Of the 210 subjects analyzed, 151 (71.9%) had hypertension. SVD progression occurred in 129 (61.4%) subjects during the 4-year study period. There were no significant differences in clinical characteristics between subjects with and without SVD progression, including no significant differences in the prevalence of hypertension or the casual BP values. There was no significant association between SVD load and cognitive function at baseline (Supplementary Table S2 ).
The ABPM findings in the whole group and in subjects with and without SVD on the first MRI are shown in Table 2 . In the whole group, the weighted SD of systolic BP, ARV of systolic BP, and weighted SD of diastolic BP were significantly different between subjects with and without SVD progression (P = 0.03, 0.04, and 0.03, respectively). In subjects with SVD, the CV of diastolic BP was also significantly different between subjects with and without SVD progression (P = 0.04). The maximum, minimum, and mean systolic and diastolic BP were not significantly different between subjects with and without SVD progression.
The incidence SVD progression was generally highest in the highest quartiles of the indices of ABP variability (Figure 3 ). In the whole group, the Cochran-Armitage test showed that higher systolic weighted SD and CV were significantly associated with progression of SVD (P trend = 0.03 and 0.03, respectively), but systolic SD was not (P trend = 0.29; data not shown) and systolic ARV showed borderline significance (P trend = 0.05). In subjects with SVD on the first MRI, systolic ARV was significantly associated with progression of SVD (P trend = 0.03).
The BPV indices were divided into 2 groups by median value (lower vs. higher) and the ORs of these ABP variability indices for the likelihood of SVD progression were calculated by logistic regression analysis (Table 3 ). In the whole group, higher systolic CV, higher diastolic weighted SD, and higher diastolic CV were significantly associated with SVD progression on univariable logistic regression analyses (OR = 1.93, 95% confidence interval (CI) = 1.10-3.40, P = 0.02; OR = 1.84, 95% CI = 1.05-3.23, P = 0.03; and OR = 1.90, 95% CI = 1.08-3.33, P = 0.03, respectively). These associations were also significant on multiple logistic regression analysis with adjustment for age, sex, conventional risk factors, and mean systolic BP (OR = 2.01, 95% CI = 1.13-3.58, P = 0.02; OR = 1.97, 95% CI = 1.06-3.64, P = 0.03; and OR = 2.01, 95% CI = 1.10-3.69, P = 0.02, respectively). In subjects with SVD, higher systolic and diastolic ARV were also significantly associated with SVD progression on univariable and multivariable logistic regression analyses (OR = 2.05, 95% CI = 1.04-4.03, P = 0.04; OR = 2.21, 95% CI = 1.07-4.53, P = 0.03, respectively, on multivariable analysis). These associations still remained significant after adjustment for antihypertensive medication use and class of antihypertensive agent (data not shown).
Comparisons between subjects with cognitive decline (n = 88) and without cognitive decline (n = 100) are shown in Table 4 . Lacunar infarction was significantly more common in subjects with cognitive decline than in those without (P = 0.048). Comparisons of the indices of ABP variability showed that only systolic ARV was significantly different between subjects with and without cognitive decline (P = 0.02). In addition, the incidence of cognitive decline was higher in the highest tertile of ARV than in the other tertiles (P trend = 0.02) (Figure 4) .
Multivariable logistic regression analysis showed that higher systolic ARV was a significant predictor of cognitive decline after adjustment for age, sex, conventional risk factors, mean ABP, and the carotid artery plaque score (Model 1; OR = 2.67, 95% CI = 1.43-4.97, P < 0.01); and after adjustment for all these factors plus WML grade (Model 2; OR = 2.70, 95% CI = 1.44-5.05, P < 0.01) (Supplementary Table S3 ). This association remained significant after adjustment for antihypertensive medication use and class of antihypertensive agent (data not shown).
Multivariable analysis using BPV as a continuous variable showed that systolic ARV was an independent predictor of both SVD progression and cognitive decline (Supplementary  Tables S4 and S5) .
DISCUSSION
This study found that increased ABP variability was associated with SVD progression, particularly in individuals with SVD at baseline. To the best of our knowledge, this is the first longitudinal cohort study to demonstrate that high systolic ARV measured by 24-hour ABPM is associated with SVD progression and cognitive decline in community-dwelling elderly Japanese individuals. These associations persisted after adjustment for confounding factors and mean systolic ABP. Our results did not show a significant association between ARV of diastolic BP and cognitive decline. This is Descriptive statistics are presented as mean ± SD. Abbreviations: ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; CCB, calcium channel blocker; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HbA1c, homoglobin A1c; HDL-C, high density lipoprotein cholesterol; IFG, impaired fasting glucose; IGT, impaired glucose torelance; MMSE, Mini-Mental State Examination; NGSP, National Glycohemoglobin Standardization Program; OGTT, oral glucose torelance test; TG, triglyceride; SVD, small vessel disease.
* P < 0.05; ** P < 0.01. Descriptive statistics are presented as mean ± SD. Abbreviations: ARV, average real variability; BP, blood pressure; CV, coefficient of variation; SVD, small vessel disease.
* P < 0.05.
consistent with the findings of other studies that shown that systolic BP has a greater impact on cardiovascular risk 20 or SVD 21 than diastolic BP. Previous studies reported relationships between several ABP parameters and cerebral SVD, especially in hypertensive subjects. 8, 14 However, most of these studies were crosssectional, and they failed to establish a causal relationship between ABP parameters and cerebral SVD. In addition, there are minimal data regarding the impact of ABP variability on SVD progression 10 and cognitive decline in community-dwelling elderly individuals. No previous longitudinal community-based studies showed associations between ARV in ABP and cerebral SVD progression or between ARV in ABP and cognitive decline. Goldstein et al. 10 conducted a 5-year longitudinal cohort study of 155 healthy elderly individuals and found that high awake BPV was a risk factor for WML progression. Only 1 previous longitudinal study demonstrated relationships between ABP and SVD progression and between ABP and cognitive decline in communitydwelling older persons. 22 However, that study did not report the relationship between ABP variability and SVD progression or between ABP variability and cognitive decline.
In our results, the incidence of cognitive decline was 52.1% in subjects with SVD progression and 37.7% in subjects without SVD progression (Table 1) . Multiple logistic regression analysis with adjustment for confounding factors showed that SVD progression was an independent predictor of cognitive decline (P = 0.047; data not shown). Although the precise mechanisms underlying BPV-related cognitive dysfunction remain unknown, these results may indicate a relationship in which ABP variability causes SVD progression and results in cognitive decline. Higher BP may initially accelerate atherosclerotic change and consequently impair cerebral autoregulation of blood flow. However, patients with advanced SVD and impaired autoregulation require higher BP for adequate brain perfusion. 23 Sudden decreases in BP in association with increased BPV may reduce perfusion of the cerebral white matter, resulting in SVD progression and cognitive decline in elderly individuals. 8 It remains unclear whether increased ARV is a cause or consequence of SVD, but the results of our study suggest that in individuals with signs of SVD on MRI, a high ARV with a sudden decrease in BP may result in advancement of cerebral SVD and cerebral hypoperfusion. Meanwhile, SVD could be a cause of BP variability. Kario et al. reported that silent cerebral infarcts were significantly associated with exaggerated morning BP surges in elderly hypertensive patients. 24 There was a prominent association between multiple cerebral infarcts and morning BP surges, which appeared to depend on adrenergic sympathetic activity. The degree of morning BP surge depends on the adrenergic vasoconstrictor response of small resistance vessels and may be closely related to small vessel remodeling. High morning BP surge, indicating short-term BP variability, and vascular remodeling of various sizes of arteries may therefore form a positive cycle of increasing cardiovascular risk. 25 Some limitations of our study require consideration. First, the potential misclassification or quantification of cerebral SVD-related lesions is a considerable methodological limitation. Previous studies reported that WML volumes assessed by quantitative techniques were superior to use of a visual rating scale for assessing cerebrovascular disease load. 26 Second, the definition of cognitive decline as a drop in the MMSE score of at least 1 point may be insufficient. The association between higher ARV and cognitive decline remained statistically significant if we defined cognitive decline as a drop in the MMSE score of at least 2 points (P < 0.01) but was not significant if we defined cognitive decline as a drop in the MMSE score of at least 3 points as in the ProFESS trial 27 (P = 0.09; data not shown). Third, variations in the antihypertensive agents used among study subjects may have affected ABP variability and cerebral blood flow, thereby Descriptive statistics are presented as mean ± SD. Abbreviations: ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARV, average real variation; CCB, calcium channel blocker; CV, coefficient of variation; SVD, small vessel disease.
influencing the relationships among BP, SVD, and cognitive function. Finally, it is possible that the fixed-time method of measuring ABPM did not detect differences in short-term BPV, especially at night when BP measurements were only obtained every 60 minutes. The relative lack of nighttime BP data may have affected the BPV values. It remains unclear whether adequate lowering of BP to prevent cerebrovascular events may be linked to acceleration of cognitive decline in elderly individuals with SVD. The results of previous studies suggest that the ABP may increase to maintain cerebral perfusion in elderly hypertensive individuals. 28 Further prospective studies are needed to evaluate the relationships among BPV, SVD progression, and cognitive decline in the community-dwelling elderly population. 
